Invention Grant
- Patent Title: Modulators of C3a receptors
- Patent Title (中): C3a受体的调节剂
-
Application No.: US14356821Application Date: 2012-11-07
-
Publication No.: US09586914B2Publication Date: 2017-03-07
- Inventor: David Fairlie , Robert C. Reid
- Applicant: THE UNIVERSITY OF QUEENSLAND
- Applicant Address: AU St. Lucia, Queensland
- Assignee: THE UNIVERSITY OF QUEENSLAND
- Current Assignee: THE UNIVERSITY OF QUEENSLAND
- Current Assignee Address: AU St. Lucia, Queensland
- Agency: Nixon & Vanderhye P.C.
- Priority: AU2011904606 20111107
- International Application: PCT/AU2012/001364 WO 20121107
- International Announcement: WO2013/067578 WO 20130516
- Main IPC: C07D263/34
- IPC: C07D263/34 ; C07D271/06 ; C07D401/12 ; C07D413/06 ; C07D413/12 ; C07D333/38 ; C07D271/10 ; C07D277/56 ; C07D307/68 ; C07D403/12 ; C07D233/90 ; A61K39/39 ; A61K39/00
Abstract:
Heterocyclic compounds that modulate C3a receptors and their use in the treatment or prevention of inflammatory diseases, infectious diseases, cancers, metabolic disorders, obesity, type 2 diabetes, metabolic syndrome and associated cardiovascular diseases are described. The use of the compounds in stimulating or suppressing an immune response is also described together with pharmaceutical compositions comprising the compounds or their pharmaceutically acceptable salts.
Public/Granted literature
- US20140302069A1 MODULATORS OF C3A RECEPTORS Public/Granted day:2014-10-09
Information query
